Posts

Being Fitter May Help Your Kidneys Age More Slowly, New Study Finds

Image
Your fitness level today could be a clue to how well your kidneys age. A new study from Japan has found that adults with higher cardiorespiratory fitness experienced a slower decline in kidney function over five years — suggesting that staying fit may help protect the kidneys long before any disease appears. The research, published in the November 2026 issue of Medicine & Science in Sports & Exercise, followed 198 adults with healthy kidney function, with a median age of 61.4 years. The team from the University of Tsukuba, led by Shun Yoshikoshi, measured each participant's cardiorespiratory fitness — the body's ability to supply oxygen during sustained activity — using a submaximal cycling test, then tracked their kidney function annually for five years. The results were clear: participants with higher fitness showed a slower decline in kidney function when it was estimated using cystatin C, a blood marker of how efficiently the kidneys filter waste. The link held even...

Your Waist Size May Matter More Than Your Weight, Massive Study of 17 Million Adults Finds

Image
Forget the number on the scale for a moment — your waistline may tell doctors far more about your health than your weight alone. A massive new study of more than 17 million adults in South Korea, published in the Journal of Epidemiology & Community Health, found that both a large waist and a very small waist are linked to a higher risk of death — no matter what a person's body mass index (BMI) says. Researchers tracked 17,252,815 adults who had routine health checks in 2009–10, following them for nearly 14 years until June 2024. During that time, about 11% of the men and 7.5% of the women died. The pattern was U-shaped: the lowest risk of death was found in men with a waist of 80–94 cm (31.5–37 inches) and women with a waist of 75–89 cm (29.5–35 inches). Risk climbed on both sides of that range — and the link held across all BMI categories and all ages, growing stronger at older ages, especially among women aged 75 and older. Among people at or above the average waist size for ...

Brisk Walking and Strength Training Are the Best Exercises for Your Bones After 40, Major BMJ Review Finds

Image
  If you are over 40 and want one habit for your bones, start with brisk walking — and add some strength training. A major review published in The BMJ in 2026, spotlighted in new coverage this week, pooled 124 randomised trials involving 18,429 adults aged 40 and above and found that exercise can slow the age-related loss of bone mineral density. Brisk walking or jogging came out on top. It was the only exercise type linked to bone density gains at all three key sites measured — the lumbar spine, the femoral neck (the top of the thigh bone) and the total hip. Combined aerobic and resistance training matched it at the spine, making the combination another strong choice. The review also gave a practical dose: clinically meaningful benefits generally appeared at around 600 MET-minutes per week — roughly two to three hours of brisk walking or jogging. For the lumbar spine, benefits could appear from about 400 MET-minutes a week. Fractures tell a slightly different story. Across 26 tria...

Your Fitness Tracker Might Actually Help You Hit Your Exercise Goals, New Study Finds

Image
If your smartwatch has been nudging you to move more, it may be doing more good than you think. A new study from the University of Mississippi, published November 16 in the journal Frontiers in Physiology, found that Americans who use wearable fitness trackers and other digital health tools are far more likely to meet federal exercise guidelines than those who barely use them. The researchers analyzed data from the 2024 Health Information National Trends Survey, a nationally representative survey of U.S. adults, covering 5,804 people. Instead of looking at one gadget at a time, they grouped people by how they combined digital health tools — wearables, health apps, patient portals, telehealth and social media — and found four distinct patterns. About one in three people who used a variety of digital health tools — for example, both a wearable fitness tracker and a patient portal — met both federal guidelines: at least 150 minutes of moderate aerobic activity each week, plus muscle-stren...

Orangetheory to Train All 6,500 Coaches for the GLP-1 Era in First-of-Its-Kind Fitness Partnership

Image
  Orangetheory Fitness is making a major bet on the future of weight loss: the popular workout chain announced on Monday, November 16, that it will train its entire global coaching network to support members taking GLP-1 medications. The company says it is the first fitness brand to partner with the National Academy of Sports Medicine (NASM) to train all of its more than 6,500 coaches worldwide. Every coach will complete NASM's "Understanding Weight Loss Medications" course, with systemwide completion targeted for February 2027. The training is designed to help coaches understand how GLP-1 and GIP medications work, their common side effects, and how to support members through exercise and lifestyle coaching. Coaches will not prescribe or manage medications — those decisions remain with each member's health care provider — and they will not ask members whether they are taking a GLP-1 drug. For members, the change comes with no separate class, sign-up or added cost. Coa...

Stopping Ozempic and Other GLP-1 Drugs May Double Heart Attack and Stroke Risk, Major Study Finds

Image
  People with type 2 diabetes who stop taking GLP-1 weight-loss and diabetes drugs such as Ozempic face nearly double the risk of a heart attack, stroke or death compared with those who stay on treatment, according to a major new study. The research, published in The Lancet Regional Health – Europe, analysed electronic medical records from more than 80,000 people with type 2 diabetes and no established heart disease, treated at 301 diabetes clinics across Italy between 2004 and 2024. The findings are striking. People who discontinued their GLP-1 treatment had about twice the combined risk of a non-fatal heart attack, a non-fatal stroke or death from any cause compared with those who continued — 3.94 events per 100 person-years versus 1.96. Death from any cause alone was around 4.8 times higher among those who stopped, at 2.23 versus 0.48 deaths per 100 person-years. More than six in ten of the patients in the study — 48,615 of 80,302 — had stopped their GLP-1 treatment by their las...

FDA Orders New Eye Warning on Ozempic, Wegovy and All GLP-1 Drugs Over Rare Vision Risk

Image
The U.S. Food and Drug Administration has ordered a new safety warning on every GLP-1 weight-loss and diabetes drug sold in the United States, after identifying a potential increased risk of a rare eye condition that can cause sudden vision loss. In a Drug Safety Communication issued on November 9, 2026, the FDA said it is requiring manufacturers of all glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to add information about non-arteritic anterior ischemic optic neuropathy, or NAION, to the Warnings and Precautions section of their product labels. NAION, often described as an "eye stroke," is caused by reduced blood flow to the optic nerve. It can cause sudden, painless vision loss in one eye, including blind spots, tunnel vision or distorted colours, and the damage is usually not reversible. The warning covers the full GLP-1 class, including Ozempic, Wegovy and Rybelsus (semaglutide), Mounjaro and Zepbound (tirzepatide), Saxenda and Victoza (liraglutide), and Trulicity...

Popular posts from this blog

Eating Less Protein Could Slow Aging, Major Review of 350 Studies Suggests

Build Muscle, Beat Diabetes: Why Strength Training Is a Powerful Tool for Blood Sugar Control This World Diabetes Day

Your Waist Size May Matter More Than Your Weight, Massive Study of 17 Million Adults Finds